- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 8 x YB: YTTERBIUM (III) ION(Non-functional Binders)
YB.2: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)YB.3: 1 residues within 4Å:- Ligands: NAI.1
No protein-ligand interaction detected (PLIP)YB.7: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)YB.8: 1 residues within 4Å:- Ligands: NAI.6
No protein-ligand interaction detected (PLIP)YB.12: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)YB.13: 1 residues within 4Å:- Ligands: NAI.11
No protein-ligand interaction detected (PLIP)YB.17: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)YB.18: 1 residues within 4Å:- Ligands: NAI.16
No protein-ligand interaction detected (PLIP)- 4 x M39: 6-{[(3-fluorophenyl)methyl]sulfanyl}-5-(2-methylphenyl)-2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(Non-covalent)
M39.4: 11 residues within 4Å:- Chain A: S.121, F.171, M.175, H.293, G.294, Y.297, C.303, Y.457, G.458, V.460, F.466
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.171, A:F.171, A:V.460
- Hydrogen bonds: A:H.293
- pi-Stacking: A:Y.297
M39.9: 11 residues within 4Å:- Chain B: S.121, F.171, M.175, H.293, G.294, Y.297, C.303, Y.457, G.458, V.460, F.466
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:F.171, B:F.171, B:V.460
- Hydrogen bonds: B:H.293
- pi-Stacking: B:Y.297
M39.14: 11 residues within 4Å:- Chain C: S.121, F.171, M.175, H.293, G.294, Y.297, C.303, Y.457, G.458, V.460, F.466
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:F.171, C:F.171, C:V.460
- Hydrogen bonds: C:H.293
- pi-Stacking: C:Y.297
M39.19: 11 residues within 4Å:- Chain D: S.121, F.171, M.175, H.293, G.294, Y.297, C.303, Y.457, G.458, V.460, F.466
5 PLIP interactions:5 interactions with chain D- Hydrophobic interactions: D:F.171, D:F.171, D:V.460
- Hydrogen bonds: D:H.293
- pi-Stacking: D:Y.297
- 4 x CL: CHLORIDE ION(Non-functional Binders)
CL.5: 3 residues within 4Å:- Chain A: R.143, T.155, H.157
Ligand excluded by PLIPCL.10: 3 residues within 4Å:- Chain B: R.143, T.155, H.157
Ligand excluded by PLIPCL.15: 3 residues within 4Å:- Chain C: R.143, T.155, H.157
Ligand excluded by PLIPCL.20: 3 residues within 4Å:- Chain D: R.143, T.155, H.157
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hurley, T.D. et al., Structure of human ALDH1A1 with inhibitor CM039. To Be Published
- Release Date
- 2017-09-27
- Peptides
- Retinal dehydrogenase 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
- 8 x YB: YTTERBIUM (III) ION(Non-functional Binders)
- 4 x M39: 6-{[(3-fluorophenyl)methyl]sulfanyl}-5-(2-methylphenyl)-2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one(Non-covalent)
- 4 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hurley, T.D. et al., Structure of human ALDH1A1 with inhibitor CM039. To Be Published
- Release Date
- 2017-09-27
- Peptides
- Retinal dehydrogenase 1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A